Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

Clinical trial NCT02049905 · COMPLETED

Trial details

NCT number: NCT02049905
Sponsor: ImmunityBio, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma

Start date: 2014-01-01
Primary completion: 2017-05-01
Enrollment: 433

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.